Review

October 19, 2021


Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Pil Soo Sung
Clin Mol Hepatol. 2022;28(3):333-350.

Review

November 26, 2021


The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, et al.
Clin Mol Hepatol. 2022;28(3):351-361.

Review

December 27, 2021


Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, et al.
Clin Mol Hepatol. 2022;28(3):362-379.

Review

January 13, 2022


Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Myung Ji Goh, Dong Hyun Sinn
Clin Mol Hepatol. 2022;28(3):380-395.

Review

January 14, 2022


Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clin Mol Hepatol. 2022;28(3):396-407.

Review

February 17, 2022


RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Clin Mol Hepatol. 2022;28(3):408-424.

Review

July 1, 2022


Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, et al.
Clin Mol Hepatol. 2022;28(3):425-472.

Original Article

March 2, 2022


Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Clin Mol Hepatol. 2022;28(3):483-496.

Original Article

April 28, 2022


Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial
Ju Hee Oh, Dae Won Jun, Hye Young Kim, et al.
Clin Mol Hepatol. 2022;28(3):497-509.

Original Article

March 17, 2022


Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, et al.
Clin Mol Hepatol. 2022;28(3):510-521.

Original Article

May 4, 2022


Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4
Yang Liu, Xin Zhang, Shuo Chen, et al.
Clin Mol Hepatol. 2022;28(3):522-539.

Original Article

May 6, 2022


Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, et al.
Clin Mol Hepatol. 2022;28(3):540-552.

Original Article

May 11, 2022


Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, et al.
Clin Mol Hepatol. 2022;28(3):553-564.

Original Article

May 19, 2022


The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
Cheng Han Ng, Kai En Chan, Yip Han Chin, et al.
Clin Mol Hepatol. 2022;28(3):565-574.


Articles in E-pub version are posted online ahead of regular printed publication.

Original Article
Forecasted 2040 Global Prevalence of NAFLD using Hierarchical Bayesian Approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Received August 6, 2022  Accepted September 17, 2022  
View: 162   Download: 23
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
Tae Hyung Kim, Joo Won Baik, Young Kul Jung, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Received August 2, 2022  Accepted September 16, 2022  
View: 132   Download: 11
Letter to the Editor
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Seogsong Jeong, Won Kim, Sang Min Park
Received September 3, 2022  Accepted September 5, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0267    [Epub ahead of print]
View: 203   Download: 14
Editorial
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Soon Sun Kim, Jae Youn Cheong
Received August 15, 2022  Accepted September 6, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0249    [Epub ahead of print]
View: 144   Download: 7
Review
HCC Surveillance in Patients with NAFLD
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Received August 13, 2022  Accepted September 5, 2022  
View: 163   Download: 14
Letter to the Editor
Forms of cholangitis to be considered after SARS-CoV-2 infection
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Received August 29, 2022  Accepted August 31, 2022  
View: 125   Download: 7
Editorial
Surveillance for hepatocellular carcinoma: It is time to move forward
Bo Hyun Kim, Yuri Cho, Joong-Won Park
Received August 25, 2022  Accepted August 30, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0257    [Epub ahead of print]
View: 173   Download: 11
Letter to the Editor
Non-alcoholic fatty liver disease and risk of dementia: A meta-analysis of cohort studies
Li-Yu Lu, Min-You Wu, Yung-Shuo Kao, Cheng-Hsien Hung
Received August 29, 2022  Accepted September 1, 2022  
View: 241   Download: 32
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Received August 2, 2022  Accepted August 29, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0233    [Epub ahead of print]
View: 182   Download: 13
Original Article
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
Received June 23, 2022  Accepted August 29, 2022  
View: 441   Download: 52
Editorial
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Received July 17, 2022  Accepted August 18, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0208    [Epub ahead of print]
View: 190   Download: 8
Original Article
HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB
Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
Received June 14, 2022  Accepted August 12, 2022  
View: 354   Download: 51
Review
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
Soo-Jeung Park, Young S. Hahn
Received February 5, 2022  Accepted August 11, 2022  
View: 574   Download: 34
Original Article
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
Received December 20, 2021  Accepted August 6, 2022  
View: 360   Download: 28
Review
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang-Wook Yi
Received December 7, 2021  Accepted April 20, 2022  
DOI: https://doi.org/10.3350/cmh.2021.0383    [Epub ahead of print]
View: 718   Download: 71
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Received April 8, 2022  Accepted July 3, 2022  
View: 571   Download: 46
Original Article
Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus
Daxian Wu, Qunfang Rao, Zhongyang Xie, Xiaoqing Zhu, Yuanmei Che, Jian Wu, Hainv Gao, Jingyu Zhang, Zhouhua Hou, Xiaoyu Cheng, Zeyu Sun
Received May 5, 2022  Accepted July 23, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0121    [Epub ahead of print]
View: 371   Download: 49
Global Prevalence of Depression and Anxiety in Patients with Hepatocellular Carcinoma: Systematic Review and Meta-analysis
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang
Received May 15, 2022  Accepted July 20, 2022  
View: 328   Download: 10
Review
WNT Signaling in Liver Regeneration, Disease, and Cancer
Gengyi Zou, Jae-Il Park
Received March 1, 2022  Accepted June 30, 2022  
View: 628   Download: 72
Snapshot
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Received June 21, 2022  Accepted June 23, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0175    [Epub ahead of print]
View: 546   Download: 55
Original Article
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
Received March 10, 2022  Accepted June 18, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0068    [Epub ahead of print]
View: 1083   Download: 109
Review
Management of Refractory Ascites
Florence Wong
Received April 17, 2022  Accepted June 7, 2022  
View: 779   Download: 168
Original Article
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Received April 11, 2022  Accepted June 7, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0099    [Epub ahead of print]
View: 713   Download: 54
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
Received April 5, 2022  Accepted May 31, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0087    [Epub ahead of print]
View: 571   Download: 48
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
Won Sohn, Danbee Kang, Minwoong Kang, Eliseo Guallar, Juhee Cho, Yong-Han Paik
Received February 9, 2022  Accepted May 30, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0037    [Epub ahead of print]
View: 419   Download: 24
Review Article
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Received March 13, 2022  Accepted May 16, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0070    [Epub ahead of print]
View: 1020   Download: 188  Citations: 2
Review
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
Sang Jin Kim, Jong Man Kim
Received March 1, 2022  Accepted April 15, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0060    [Epub ahead of print]
View: 667   Download: 43
Review Article
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Sung Hak Lee, Hyun-Jong Jang
Received December 20, 2021  Accepted April 17, 2022  
DOI: https://doi.org/10.3350/cmh.2021.0394    [Epub ahead of print]
View: 704   Download: 99
Subclinical versus advanced forms of alcohol-related liver disease: need for early detection
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller
Received January 18, 2022  Accepted April 11, 2022  
View: 504   Download: 30
Review
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Received January 15, 2022  Accepted March 11, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0015    [Epub ahead of print]
View: 1049   Download: 104  Citation: 1
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
Youngseok Lee, Jong-Hoon Kim
Received December 13, 2021  Accepted February 25, 2022  
DOI: https://doi.org/10.3350/cmh.2021.0390    [Epub ahead of print]
View: 7268   Download: 91  Citation: 1

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

  • PubMed Central
  • PubMed
  • Scopus
  • KoreaMed
  • KoMCI
  • ScienceCentral
  • DOAJ
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • Metadata
  • ORCID
  • MeSH on Demand
  • COPE
  • EMBASE
  • KOFST
  • ICMJE
  • Web of SCIENCE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 303
TOTAL : 973669
Close layer